Home > Income Statement > INDO US BIOTECH

INDO US BIOTECH
Revenue

    Back to Income Statement
INDO US BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹104 Cr₹73 Cr₹62 Cr₹50 Cr₹40 Cr

What is the latest Revenue of INDO US BIOTECH ?

The latest Revenue ratio of INDO US BIOTECH is ₹104 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹104 Cr
Mar2024₹73 Cr
Mar2023₹62 Cr
Mar2022₹50 Cr
Mar2021₹40 Cr

How is Revenue of INDO US BIOTECH Trending?

Years Revenue % Change
Mar2025 ₹104 Cr
42.56
Mar2024 ₹73 Cr
17.96
Mar2023 ₹62 Cr
23.36
Mar2022 ₹50 Cr
24.86
Mar2021 ₹40 Cr -

Compare Revenue of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹259.1 Cr -0.8% -0.3% -48.8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,770.3 Cr -5.4% -4.2% -31% Stock Analytics
KAVERI SEED COMPANY ₹5,503.0 Cr 7.1% 1.1% 15.6% Stock Analytics
VENKYS (INDIA) ₹1,912.2 Cr -0.2% -7.4% -23.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,229.5 Cr -4.1% -3.1% -27.1% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹455.1 Cr -0.7% -18.5% 15.7% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-0.8%

-0.3%

-48.8%

SENSEX

1.6%

2.7%

6.3%


You may also like the below Video Courses